GOVX

GeoVax Labs, Inc. - Common Stock (GOVX)

About GeoVax Labs, Inc. - Common Stock (GOVX)

GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola-Zaire, Ebola-Sudan, Lassa, Marburg, Zika virus and malaria. The company was founded in June 1988 and is headquartered in Smyrna, GA.

Details

Daily high

$1.80

Daily low

$1.46

Price at open

$1.78

52 Week High

$34.75

52 Week Low

$0.96

Market cap

5.1M

Dividend yield

0.00%

Volume

560,174

Avg. volume

461,467

P/E ratio

-.06

GeoVax Labs, Inc. - Common Stock News